Gujrathi Sheila

Chief Medical Officer at Receptos, Inc. · on record since May 14, 2013
Director at FIVE PRIME THERAPEUTICS, INC. · on record since Dec 3, 2015
Director at Processa Pharmaceuticals, Inc. · on record since Jul 30, 2026
Director at Janux Therapeutics, Inc. · on record since Jun 10, 2021
Director at BlossomHill Therapeutics, Inc. · on record since Aug 6, 2026
Director at Gossamer Bio, Inc. · on record since Mar 26, 2019
President & CEO at Gossamer Bio, Inc. · on record since Mar 26, 2019
Director at Turning Point Therapeutics, Inc. · on record since Apr 24, 2019
Director at Ventyx Biosciences, Inc. · on record since Oct 25, 2021

Insider trading activity of Gujrathi Sheila

Transactions on record: 55; since May 14, 2013

Open-market buys: 2; $468.3K

Open-market sells: 3; $8.5M

Companies traded: 7; last filing Jul 30, 2026

Figures computed from official regulatory filings — .

Companies where Gujrathi Sheila has traded

Processa Pharmaceuticals, Inc.2 tx · Jul 30, 2026
Ventyx Biosciences, Inc.21 tx · $4.3M · Mar 4, 2026
Janux Therapeutics, Inc.8 tx · Jun 13, 2025
Turning Point Therapeutics, Inc.2 tx · Jun 17, 2020
Gossamer Bio, Inc.7 tx · $168K · Feb 19, 2020
FIVE PRIME THERAPEUTICS, INC.3 tx · May 12, 2017
12 tx · $49.3M · Aug 27, 2015

Track record of Gujrathi Sheila

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Gujrathi Sheila

Co-insiders of Gujrathi Sheila

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Processa Pharmaceuticals, Inc.Listing on record	Jul 30, 2026	AwardD (derivative)	70,811.88	—	n/a (No price was disclosed in the filing)		SEC
Processa Pharmaceuticals, Inc.Listing on record	Jul 30, 2026	AwardD (derivative)	12,311.28	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	Other	-130,000	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-33,000	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-277,941	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-662,369	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-21,825	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-15,937	—	n/a (No price was disclosed in the filing)		SEC
Janux Therapeutics, Inc.Listing on record	Jun 13, 2025	AwardD (derivative)	11,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Janux Therapeutics, Inc.Listing on record	Jun 13, 2025	Award	3,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Jun 6, 2025	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Dec 26, 2024	Buy	130,000	2.31 USD	$300.3K	conv 68First in 12mo	SEC
Janux Therapeutics, Inc.Listing on record	Nov 7, 2024	Other	4,611	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Janux Therapeutics, Inc.Listing on record	Jun 28, 2024	AwardD (derivative)	8,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Janux Therapeutics, Inc.Listing on record	Jun 28, 2024	Award	2,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Jun 7, 2024	AwardD (derivative)	33,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Janux Therapeutics, Inc.Listing on record	Mar 4, 2024	Other	2,986	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Jan 23, 2024	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Janux Therapeutics, Inc.Listing on record	Jun 16, 2023	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Jun 12, 2023	AwardD (derivative)	15,937	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Apr 26, 2023	AwardD (derivative)	21,825	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 31, 2023	Exercise	100,000	6.03 USD	$603K		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 31, 2023	Sell	-100,000	33.73 USD	$3.4M		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Processa Pharmaceuticals, Inc.Listing on record	Jul 30, 2026	AwardD (derivative)	70,811.88	—	n/a (No price was disclosed in the filing)		SEC
Processa Pharmaceuticals, Inc.Listing on record	Jul 30, 2026	AwardD (derivative)	12,311.28	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	Other	-130,000	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-33,000	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-277,941	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-662,369	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-80,000	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-21,825	—	n/a (No price was disclosed in the filing)		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 4, 2026	OtherD (derivative)	-15,937	—	n/a (No price was disclosed in the filing)		SEC
Janux Therapeutics, Inc.Listing on record	Jun 13, 2025	AwardD (derivative)	11,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Janux Therapeutics, Inc.Listing on record	Jun 13, 2025	Award	3,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Jun 6, 2025	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Dec 26, 2024	Buy	130,000	2.31 USD	$300.3K	conv 68First in 12mo	SEC
Janux Therapeutics, Inc.Listing on record	Nov 7, 2024	Other	4,611	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Janux Therapeutics, Inc.Listing on record	Jun 28, 2024	AwardD (derivative)	8,350	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Janux Therapeutics, Inc.Listing on record	Jun 28, 2024	Award	2,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Jun 7, 2024	AwardD (derivative)	33,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Janux Therapeutics, Inc.Listing on record	Mar 4, 2024	Other	2,986	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Jan 23, 2024	AwardD (derivative)	80,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Janux Therapeutics, Inc.Listing on record	Jun 16, 2023	AwardD (derivative)	12,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Jun 12, 2023	AwardD (derivative)	15,937	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Apr 26, 2023	AwardD (derivative)	21,825	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 31, 2023	Exercise	100,000	6.03 USD	$603K		SEC
Ventyx Biosciences, Inc.Listing unverified	Mar 31, 2023	Sell	-100,000	33.73 USD	$3.4M		SEC